Author:
Bhal Subhasmita,Das Biswajit,Sinha Saptarshi,Das Chinmay,Acharya Sushree Subhadra,Maji Joydeb,Kundu Chanakya Nath
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, et al. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121: 105451.
2. Das C, Dash SR, Sinha S, Paul S, Das B, Bhal S, et al. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300. Med Oncol. 2023;40:351.
3. Bhal S, Kundu CN. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Med Oncol. 2023;40:82.
4. Kuang Y, Kang J, Li H, Liu B, Zhao X, Li L, et al. Multiple functions of p21 in cancer radiotherapy. J Cancer Res Clin Oncol. 2021;147:987–1006.
5. Yoshida H, Yoshimura H, Matsuda S, Yamamoto S, Ohmori M, Ohta K, et al. Celecoxib suppresses lipopolysaccharide-stimulated oral squamous cell carcinoma proliferation in vitro and in vivo. Oncol Lett. 2019;18:5793–800.